Publications by authors named "Patrick Verschueren"

Claim this Profile
T
The Patient-Reported Outcomes Measurement Information System scale v1.2 Global Health (PROMIS-GH) is useful to assess mental and physical health in individuals with chronic musculoskeletal pain, rheumatoid arthritis, hip/knee osteoarthritis, or people undergoing physiotherapy: Results of factor and item response theory analyses.
Emanuele M Giusti, Leonardo Pellicciari, Martine H P Crins, Paul Dekker, Martin van der Esch, Patrick Verschueren

Arthritis Care Res (Hoboken)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass spectrometry-based analysis of rheumatoid factor.
Jonas De Leeuw, Birthe Michiels, Rita Derua, Tom Dehaemers, Doreen Dillaerts, Patrick Verschueren

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum calprotectin and complement factor C3 are superior biomarkers of inflammation in early psoriatic arthritis as compared with C-reactive protein.
Alla Ishchenko, Margot Van Mechelen, Sofia Pazmino, Lies Storms, Barbara Neerinckx, Patrick Verschueren

RMD Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and patient-reported impact of on-flare retreatment in patients with rheumatoid arthritis: insights from retrospective long-term real-world data.
Delphine Bertrand, Elias De Meyst, Michaël Doumen, Diederik De Cock, Johan Joly, Patrick Verschueren

BMC Rheumatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mobile app to support self-management and remotely monitor disease impact in rheumatoid arthritis: the randomized controlled AEGORA trial.
Michaël Doumen, Elias De Meyst, Delphine Bertrand, Sofia Pazmino, Marine Piessens, Patrick Verschueren

Rheumatology (Oxford)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCE1: A new cytoplasmic autoantibody target in systemic sclerosis-associated interstitial lung disease.
Jean-Baptiste Vulsteke, Jan Lenaerts, Doreen Dillaerts, Patrick Verschueren, Wim A Wuyts

Autoimmun Rev· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-physician discordance impairs outcomes in early rheumatoid arthritis through less consistent treat-to-target implementation.
Michaël Doumen, Veerle Stouten, Sofia Pazmino, Elias De Meyst, Delphine Bertrand, Patrick Verschueren

Rheumatology (Oxford)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung ultrasound outperforms symptom-based screening to detect interstitial lung disease associated with rheumatoid arthritis.
Marie Vermant, Alexandros Kalkanis, Joseph Jacob, Tinne Goos, Emanuela Elsa Cortesi, Patrick Verschueren

RMD Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occupational history questionnaire for job coding and exposure assessment in systemic autoimmune rheumatic diseases.
Anne-Catherine Dens, Hannelore Celen, Stijn Michiels, Michaël Doumen, Sofia Pazmino, Patrick Verschueren

Rheumatol Adv Pract· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating pretest probability for rheumatoid arthritis with likelihood ratios of RF and ACPA to improve clinical utility of rheumatoid arthritis autoantibody testing.
Daphné Vandebeek, Elke Lodewijckx, Lieve Van Hoovels, Patrick Verschueren, Xavier Bossuyt

Clin Chim Acta· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study.
Rene Westhovens, Kevin L Winthrop, Arthur Kavanaugh, Maria Greenwald, Lorenzo Dagna, Patrick Verschueren

RMD Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New WHO ACPA standard enables standardisation among anti-CCP2 assays, but not other ACPA assays using different antigens.
Lieve Van Hoovels, Liesbeth E Bakker-Jonges, Dina Vara, Caroline Bijnens, Lucy Studholme, Patrick Verschueren

Ann Rheum Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early and sustained remission or low disease activity after first-line therapy in rheumatoid arthritis.
Patrick Vandormael, Sukayna Fadlallah, Pieter Ruytinx, Astrid Pues, Ellen Sleurs, Patrick Verschueren

RMD Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of implementing a vaccination tool in the electronic medical record on vaccination coverage of patients with immune-mediated inflammatory diseases: a prospective cohort study.
Liselotte Fierens, Sofie Coenen, Johan Joly, Tine Vanhoutvin, Els De Dycker, Patrick Verschueren

Infect Dis (Lond)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treat-to-target fixed dose rituximab retreatment versus fixed interval retreatment with disease activity-guided rituximab dose optimisation for patients with rheumatoid arthritis: study protocol for a multicentre randomised controlled superiority trial focusing on long-term disease impact (RITUXERA).
Elias De Meyst, Delphine Bertrand, Johan Joly, Michaël Doumen, Anja Marchal, Patrick Verschueren

Trials· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study.
Maya H Buch, Daniel Aletaha, Bernard G Combe, Yoshiya Tanaka, Roberto Caporali, Patrick Verschueren

RMD Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study).
Jeroen Geldof, Marie Truyens, João Sabino, Marc Ferrante, Jo Lambert, Patrick Verschueren

Vaccines (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individuals with ACPA-negative clinically suspect arthralgia experience more symptom burden: is seronegative disease truly less severe?
Michaël Doumen, René Westhovens, Patrick Verschueren

Rheumatology (Oxford)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitions of rheumatoid arthritis flare and how they relate to patients' perspectives: A scoping review of qualitative and quantitative evidence.
Michaël Doumen, Lotte Diricks, Joppe Hermans, Delphine Bertrand, Elias De Meyst, Patrick Verschueren

Semin Arthritis Rheum· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial.
Delphine Bertrand, Johan Joly, Barbara Neerinckx, Patrick Durez, Jan Lenaerts, Patrick Verschueren

RMD Open· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' and rheumatologists' perceptions on dose reduction of rituximab in rheumatoid arthritis.
Delphine Bertrand, Anke Deprez, Michaël Doumen, Diederik De Cock, Sofia Pazmino, Patrick Verschueren

Musculoskeletal Care· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician estimates of inflammation, damage and distress in rheumatoid arthritis: how can they be used to improve patient care?
Michaël Doumen, Elias De Meyst, Patrick Verschueren

Rheumatol Adv Pract· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of rheumatoid arthritis: is it time to revise the criteria?
Guenter Steiner, Patrick Verschueren, Lieve Van Hoovels, Paul Studenic, Xavier Bossuyt

RMD Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity.
Luna Dillemans, Karen Yu, Alexandra De Zutter, Sam Noppen, Mieke Gouwy, Patrick Verschueren

Cell Commun Signal· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To flare or not to flare: patients' and rheumatologists' perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis.
Delphine Bertrand, Anke Deprez, Michaël Doumen, Diederik De Cock, Sofia Pazmino, Patrick Verschueren

Ther Adv Musculoskelet Dis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis